Back

Safety and efficacy of immune checkpoint inhibitors in patients with pre-treatment reduced left ventricular function

1 September 2024 (12:00 - 12:50)
Organised by: Logo
Congress Presentation Part of: Cardio-oncology: predicting adverse effects and prognosis Cardio-Oncology ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Moaad Slieman

Tel Aviv Sourasky Medical Center, Tel Aviv (Israel)

9 More presentations in this session

Presentation thumbnail
Adverse Myocardial and vascular side effects of Immune Checkpoint Inhibitors: a prospective multimodal cardiovascular assessment (AMICI study)
Doctor M. Mirabel (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Cardiovascular outcomes in acute coronary syndrome patients with cancer: a statewide population-linkage study
Doctor C. Yu (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
The CTOX-Score, a clinical risk prediction tool for cardiovascular toxicity secondary to cancer therapies
Doctor J. Gonzalez Juanatey (Santiago de Compostela, ES)
Abstract Slides Video
Presentation thumbnail
Fibroblast activation in cardio-oncology
Doctor K. Loganath (Southampton, GB)
Abstract Slides Video
Presentation thumbnail
Sodium-glucose co-transporter-2 inhibitors : a potential cardioprotective agent?
Doctor T. Georgopoulou (Heraklion, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Cardio-oncology: predicting adverse effects and prognosis

The Event

Event poster

ESC Congress 2024

1 September 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular adverse events in primary lung cancer patients treated with immune checkpoint inhibitors: a nationwide database study
thumbnail
Congress Presentation
Immune checkpoint inhibitor myocarditis
thumbnail
Congress Presentation
Heart failure hospitalization and outcomes in cancer patients undergoing immune checkpoint inhibitor treatment: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources